GRAIL, Inc. is a biotechnology company headquartered in Menlo Park, California, founded in 2015, specializing in early cancer detection through advanced biotechnology and genomics. The company develops and commercializes the Galleri test, a…
HQ: Menlo Park, CA, United States of Americawww.grail.com
USD115.89-4.50%vs prev. close
Performance
1W
+1.86%
1M
-13.54%
3M
+77.83%
1Y
+43.15%
YTD
+41.78%
Valuation
P/E
—
EPS TTM
-9.22
Dividend yield
—
Size and risk
Market cap
$5.5B
Beta
2.87
Price history
GRAL price
USD
Total returnEventsVs index
Loading…
Next earnings
Report date
EPS estimate
Revenue estimate
Peer comparison
GRAIL
GRAL
Diagnostics & Research
Mkt cap (USD bn)
5.5
P/E
—
Div yld
—
1W
+1.9%
1M
-13.5%
3M
+77.8%
6M
+96.4%
1Y
+43.1%
YTD
+41.8%
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
GRAIL
GRAL
Diagnostics & Research
5.5
—
—
+1.9%
-13.5%
+77.8%
+96.4%
+43.1%
+41.8%
Subscribe to Equity Analytics to compare GRAL with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.